TABLE 2.

Summary of ²²⁵Ac-PRIT Therapy Results

Parameter	Long-term survivors*	nBLI AUC†	Median survival (d)	Log-rank P (vs. no treatment)	Log-rank P (vs. 1-cycle GPA33)	Log-rank P (vs. HER2 BsAb only)	Log-rank P (vs. 1-cycle HER2 only)
No treatment	2/8	18,737	112
One-cycle GPA33	2/10	3,558	105	0.9397
HER2 BsAb only	6/9	1,036	>154	0.1536	0.0923
One-cycle HER2	8/10	0.97	>154	0.0093	0.0047	0.2055
Two-cycle HER2	9/10	4.75	>154	0.0170	0.0076	0.2763	0.6717

^*At 133 d after tumor inoculation.

^†Supplemental Figure 8 provides normalized BLI data.

nBLI = normalized BLI; AUC = area under curve.